ArticleOncogene2018

Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3.

Jinnan Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.